Biotech entity
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention DFT (Density Functional Theory), the most common co-covered peer. The tracked stories average 2 original sources each. FluxMateria appears in 1 tracked Biotech story from March 21, 2026.
Last mentioned: Mar 21, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Of the tracked stories, 1 of 1 also mention DFT (Density Functional Theory), the most common co-covered peer. The tracked stories average 2 original sources each. FluxMateria appears in 1 tracked Biotech story from March 21, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering FluxMateria. Shared-story counts are live from our verified record — not editorial picks.
FluxMateria has launched a deterministic physics-based screening platform that operates 3.6 million times faster than traditional Density Functional Theory (DFT). By eschewing probabilistic AI in favor of a unified physics kernel, the platform offers a breakthrough in molecular and materials R&D efficiency.
Source: weeklyvoice.com · palmbeachpost.com
FluxMateria is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
